- Skip to main content: Latino/SBC/Fox Business (Home/Slideshow/Interactive: Fox News/SBC/Latino/Fox Business)
- Skip to main content: Fox News/Fox Business (Article Page: Fox News/SBC/Latino/Fox Business)
- Fox News Digital Network
- Fox News
- Fox Business
- uReport
- Fox News Radio
- Fox News Latino
- Fox Nation
- Fox News Insider
Account
GERN
Last Update
Change
Volume / Avg.
Prev. Close
Today's Performance
52-Week Range
Geron Corporation
- Sector: Health Care
- Industry: Drugs
- Website: www.geron.com
Geron Corporation develops therapeutic products for cancer that inhibit telomerase. Its product candidate include Imetelstat, a telomerase inhibitor, which is in Phase II clinical trials.
Follow
-
Quotes delayed at least 15 minutes. Real-time quotes provided by BATS Exchange. Market Data provided by Interactive Data (Terms & Conditions). Powered and Implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund and ETF data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions.
This material may not be published, broadcast, rewritten, or redistributed. ©2013 FOX News Network, LLC. All rights reserved.